Importantly, results from human clinical sample surveys using TCGA database and Oncolnc (http://www.oncolnc.org/) also revealed that the RCC patients with higher ANGPT-2 expression had a poor overall survival, although there is no statistical significance (p = 0.26, Fig. 3g). The gene discussed is ANGPT2; the disease is renal cell carcinoma.